Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
500 participants
OBSERVATIONAL
2013-04-30
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of North American Ginseng on Blood Pressure in Individuals With Hypertension
NCT00219960
The Evaluation and Standardization of Ginseng and Its Components for Blood Pressure Regulation
NCT00730951
Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation
NCT00728221
Effects of Ginseng and Ginkgo on Drug Disposition in Man
NCT00029692
Korean Red Ginseng Rg3 Extract on Arterial Stiffness and Blood Pressure
NCT01951443
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This systematic review and meta-analysis will follow The Cochrane Handbook for Systematic Reviews of Interventions. MEDLINE, EMBASE, CINAHL and The Cochrane Central Register of Controlled Trials will be searched using appropriate search terms. Intervention trials that investigate the effect of ginseng on blood pressure in humans will be included.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginseng
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* randomized treatment allocation
* ≥ 1 month
* suitable control
* viable endpoint data
Exclusion Criteria
* non-randomized treatment allocation
* \< 1 month
* lack of a suitable control
* no viable endpoint data
* trials where ginseng is part of a multi-herbal treatment
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Unity Health Toronto
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vladimir Vuksan
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vladimir Vuksan, PhD
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
John Sievenpiper, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Unity Health Toronto
Allison Komishon, MSc(c)
Role: STUDY_DIRECTOR
Unity Health Toronto
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Toronto 3D Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MetaBPG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.